1	Alpha-tocopherol	Alpha-tocopherol	_	_	_	_	_	_	_
2	inhibits	inhibit	_	_	_	_	_	_	_
3	agonist-induced	agonist-induced	_	_	_	_	_	_	_
4	monocytic	monocytic	_	_	_	_	_	_	_
5	cell	cell	_	_	_	_	_	_	_
6	adhesion	adhesion	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	cultured	culture	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	endothelial	endothelial	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Antioxidants	antioxidant	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	been	be	_	_	_	_	_	_	_
4	proposed	propose	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	be	be	_	_	_	_	_	_	_
7	anti-atherosclerotic	anti-atherosclerotic	_	_	_	_	_	_	_
8	agents	agent	_	_	_	_	_	_	_
9	;	;	_	_	_	_	_	_	_
10	however	however	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	mechanisms	mechanism	_	_	_	_	_	_	_
14	underlying	underlie	_	_	_	_	_	_	_
15	their	their	_	_	_	_	_	_	_
16	beneficial	beneficial	_	_	_	_	_	_	_
17	effects	effect	_	_	_	_	_	_	_
18	are	be	_	_	_	_	_	_	_
19	poorly	poorly	_	_	_	_	_	_	_
20	understood	understand	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	examined	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	effect	effect	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	alpha-tocopherol	alpha-tocopherol	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	alpha-tcp	alpha-tcp	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	on	on	_	_	_	_	_	_	_
12	one	one	_	_	_	_	_	_	_
13	cellular	cellular	_	_	_	_	_	_	_
14	event	event	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	atherosclerotic	atherosclerotic	_	_	_	_	_	_	_
17	plaque	plaque	_	_	_	_	_	_	_
18	development	development	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	monocyte	monocyte	_	_	_	_	_	_	_
21	adhesion	adhesion	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	stimulated	stimulate	_	_	_	_	_	_	_
24	endothelial	endothelial	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	ECs	EC	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Human	human	_	_	_	_	_	_	_
2	umbilical	umbilical	_	_	_	_	_	_	_
3	vein	vein	_	_	_	_	_	_	_
4	ECs	ec	_	_	_	_	_	_	_
5	were	be	_	_	_	_	_	_	_
6	pretreated	pretreate	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	alpha-tcp	alpha-tcp	_	_	_	_	_	_	_
9	before	before	_	_	_	_	_	_	_
10	stimulation	stimulation	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	known	known	_	_	_	_	_	_	_
13	agonists	agonist	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	monocyte	monocyte	_	_	_	_	_	_	_
16	adhesion	adhesion	_	_	_	_	_	_	_
17	:	:	_	_	_	_	_	_	_
18	IL-1	IL-1	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	10	10	_	_	_	_	_	_	_
21	ng/ml	ng/ml	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	LPS	LPS	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	10	10	_	_	_	_	_	_	_
27	ng/ml	ng/ml	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	thrombin	thrombin	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	30	30	_	_	_	_	_	_	_
33	U/ml	U/ml	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	or	or	_	_	_	_	_	_	_
37	PMA	PMA	_	_	_	_	_	_	_
38	(	(	_	_	_	_	_	_	_
39	10	10	_	_	_	_	_	_	_
40	nM	nM	_	_	_	_	_	_	_
41	)	)	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	Agonist-induced	agonist-induced	_	_	_	_	_	_	_
2	monocytic	monocytic	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	adhesion	adhesion	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	but	but	_	_	_	_	_	_	_
7	not	not	_	_	_	_	_	_	_
8	basal	basal	_	_	_	_	_	_	_
9	adhesion	adhesion	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	inhibited	inhibit	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	time-	time-	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	concentration-dependent	concentration-dependent	_	_	_	_	_	_	_
18	manner	manner	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	alpha-tcp	alpha-tcp	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	IC50	ic50	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	alpha-tcp	alpha-tcp	_	_	_	_	_	_	_
5	on	on	_	_	_	_	_	_	_
6	an	an	_	_	_	_	_	_	_
7	IL-1-induced	il-1-induced	_	_	_	_	_	_	_
8	response	response	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	45	45	_	_	_	_	_	_	_
11	microM	microM	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	correlated	correlate	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	decrease	decrease	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	steady	steady	_	_	_	_	_	_	_
9	state	state	_	_	_	_	_	_	_
10	levels	level	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	E-selectin	E-selectin	_	_	_	_	_	_	_
13	mRNA	mRNA	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	surface	surface	_	_	_	_	_	_	_
17	expression	expression	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	E-selectin	E-selectin	_	_	_	_	_	_	_
20	which	which	_	_	_	_	_	_	_
21	is	be	_	_	_	_	_	_	_
22	consistent	consistent	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	ability	ability	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	a	a	_	_	_	_	_	_	_
28	monoclonal	monoclonal	_	_	_	_	_	_	_
29	antibody	antibody	_	_	_	_	_	_	_
30	to	to	_	_	_	_	_	_	_
31	E-selectin	E-selectin	_	_	_	_	_	_	_
32	to	to	_	_	_	_	_	_	_
33	inhibit	inhibit	_	_	_	_	_	_	_
34	monocytic	monocytic	_	_	_	_	_	_	_
35	cell	cell	_	_	_	_	_	_	_
36	adhesion	adhesion	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	this	this	_	_	_	_	_	_	_
39	system	system	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Probucol	Probucol	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	50	50	_	_	_	_	_	_	_
4	microM	microM	_	_	_	_	_	_	_
5	)	)	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	N-acetylcysteine	N-acetylcysteine	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	20	20	_	_	_	_	_	_	_
10	mM	mM	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	also	also	_	_	_	_	_	_	_
13	inhibited	inhibit	_	_	_	_	_	_	_
14	agonist-induced	agonist-induced	_	_	_	_	_	_	_
15	monocytic	monocytic	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	adhesion	adhesion	_	_	_	_	_	_	_
18	;	;	_	_	_	_	_	_	_
19	whereas	whereas	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	several	several	_	_	_	_	_	_	_
22	other	other	_	_	_	_	_	_	_
23	antioxidants	antioxidant	_	_	_	_	_	_	_
24	had	have	_	_	_	_	_	_	_
25	no	no	_	_	_	_	_	_	_
26	significant	significant	_	_	_	_	_	_	_
27	effect	effect	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Protein	protein	_	_	_	_	_	_	_
2	kinase	kinase	_	_	_	_	_	_	_
3	C	C	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	PKC	PKC	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	does	do	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	appear	appear	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	play	play	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	role	role	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	alpha-tcp	alpha-tcp	_	_	_	_	_	_	_
17	effect	effect	_	_	_	_	_	_	_
18	since	since	_	_	_	_	_	_	_
19	no	no	_	_	_	_	_	_	_
20	suppression	suppression	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	phosphorylation	phosphorylation	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	PKC	PKC	_	_	_	_	_	_	_
25	substrates	substrate	_	_	_	_	_	_	_
26	was	be	_	_	_	_	_	_	_
27	observed	observe	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	transcription	transcription	_	_	_	_	_	_	_
5	factor	factor	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	reported	report	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	be	be	_	_	_	_	_	_	_
12	necessary	necessary	_	_	_	_	_	_	_
13	but	but	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	sufficient	sufficient	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	E-selectin	E-selectin	_	_	_	_	_	_	_
18	expression	expression	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	EC.	EC.	_	_	_	_	_	_	_
21	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
22	mobility	mobility	_	_	_	_	_	_	_
23	shift	shift	_	_	_	_	_	_	_
24	assays	assay	_	_	_	_	_	_	_
25	failed	fail	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	show	show	_	_	_	_	_	_	_
28	an	an	_	_	_	_	_	_	_
29	alpha-tcp-induced	alpha-tcp-induced	_	_	_	_	_	_	_
30	decrease	decrease	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	activation	activation	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	this	this	_	_	_	_	_	_	_
35	transcription	transcription	_	_	_	_	_	_	_
36	factor	factor	_	_	_	_	_	_	_
37	after	after	_	_	_	_	_	_	_
38	cytokine	cytokine	_	_	_	_	_	_	_
39	stimulation	stimulation	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	has	have	_	_	_	_	_	_	_
3	been	be	_	_	_	_	_	_	_
4	hypothesized	hypothesize	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	alpha-tcp	alpha-tcp	_	_	_	_	_	_	_
7	acts	act	_	_	_	_	_	_	_
8	as	as	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	anti-atherosclerotic	anti-atherosclerotic	_	_	_	_	_	_	_
11	molecule	molecule	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	inhibiting	inhibit	_	_	_	_	_	_	_
14	generation	generation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	oxidized	oxidize	_	_	_	_	_	_	_
17	LDL–a	LDL–a	_	_	_	_	_	_	_
18	putative	putative	_	_	_	_	_	_	_
19	triggering	trigger	_	_	_	_	_	_	_
20	molecule	molecule	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	atherosclerotic	atherosclerotic	_	_	_	_	_	_	_
24	process	process	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	point	point	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	novel	novel	_	_	_	_	_	_	_
7	alternative	alternative	_	_	_	_	_	_	_
8	mechanism	mechanism	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	action	action	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	alpha-tcp	alpha-tcp	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

